Instrumentation Laboratory GEM Premier 5000 cartridges recalled for repeated ejection errors
Some GEM PAK cartridges for the GEM Premier 5000 blood analyzer are experiencing repeated "Process Control Solution Not Detected" errors during startup, causing the cartridges to be ejected and requiring replacement. This can delay test results. The affected cartridges are lot numbers 251114K, 251205K, and 251215D (Part No. 00055430011).
From the FDA notice · Read the official notice ↗ · All Instrumentation Laboratory recalls
What to do
- If you operate a GEM Premier 5000, monitor cartridge performance during warm-up
- If a cartridge is repeatedly ejected, replace it with a new one
- Plan ahead for potential operational delays if multiple cartridges fail in sequence
- Contact Instrumentation Laboratory if you have questions about affected lot numbers
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- GEM Premier 5000; Part No. 00055430011.
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 20 products — see all of them.
Details
- Units affected
- 25 units
- Illnesses reported
- None reported
- Manufactured in
- 180 Hartwell Rd, N/A, Bedford, MA, United States
- Classification
- Class II
- Recall number
- Z-1540-2026
In the FDA's words
- Description
- GEM Premier 5000; Part No. 00055430011. Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact. Part number: 00055430011; UDI: 08426950807766; Lots No.: 251114K, 251205K, 251215D. Distribution: Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada, Chile, China, Colombia, Czech Republic, Germany, Denmark, Dominican Republic, Ecuador, Estonia, Spain, Finland, France, United Kingdom, Georgia, Greece, Guatemala, Hong Kong, Croatia, Hungary, Indonesia, Ireland, Israel, India, Italy, Jordan, Japan, South Korea, Kazakhstan, Lebanon, Lithuania, Luxembourg, Latvia, Macau, Mexico, Malaysia, Netherlands, New Zealand, Oman, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Serbia, Saudi Arabia, Sweden, Singapore, Slovenia, San Marino, South Africa, Thailand, Tunisia, Turkey, Uruguay, Uzbekistan & Vietnam. Affected quantity: 25 units
- Hazard
- Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.
20 products in this recall
Instrumentation Laboratory GEM Premier 5000 PAKs recalled for test errors
Instrumentation Laboratory is recalling 20 GEM PAK cartridges for the GEM Premier 5000 system. Customers reported that the cartridges may show 'Process Control Solution Not Detected' (PCSND) errors during warm-up, sometimes repeatedly, which ejects the cartridge and requires inserting a new one. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- GEM Premier 5000 PAK, Part No. 00055360004.Z-1524-2026 · 51 units
- GEM Premier 5000 PAK; Part No. 00055360008.Z-1525-2026 · 30 units
- GEM Premier 5000 PAK; Part No. 00055360010.Z-1526-2026 · 1,225 units
- GEM Premier 5000 PAK; Part No. 00055360011.Z-1527-2026 · 10 units
- GEM Premier 5000 PAK; Part No. 00055407504.Z-1528-2026 · 489 units
- GEM Premier 5000 PAK; Part No. 00055407508.Z-1529-2026 · 180 units
- GEM Premier 5000 PAK; Part No. 00055407510.Z-1530-2026 · 1,126 units
- GEM Premier 5000 PAK; Part No. 00055407511.Z-1531-2026 · 27 units
- GEM Premier 5000 PAK; Part No. 00055415004.Z-1532-2026 · 352 units
- GEM Premier 5000; Part No. 00055415005.Z-1533-2026 · 8 units
- GEM Premier 5000; Part No. 00055415008.Z-1534-2026 · 195 units
- GEM Premier 5000; Part No. 00055415010.Z-1535-2026 · 1,629 units
- GEM Premier 5000; Part No: 00055415011.Z-1536-2026 · 7 units
- GEM Premier 5000; Part No. 00055430004.Z-1537-2026 · 253 units
- GEM Premier 5000; Part No. 00055430008.Z-1538-2026 · 74 units
- GEM Premier 5000; Model No. 00055430010.Z-1539-2026 · 1,607 units
- GEM Premier 5000; Part No. 00055430011. (this page)Z-1540-2026 · 25 units
- GEM Premier 5000; Part No. 00055445004.Z-1541-2026 · 130 units
- GEM Premier 5000; Part No. 00055445008.Z-1542-2026 · 70 units
- GEM Premier 5000; Part No. 00055445010 & 00055445011.Z-1543-2026 · 1,989 units
More from Instrumentation Laboratory
See all- HemosIL AcuStar HIT-IgG test recalled for possible result bias
SeriousFDAOct 21, 2026
- GEM Premier 7000 PAKs recalled for off-spec solution
ModerateFDAAug 12, 2026